Farideh Ghalamfarsa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Farideh Ghalamfarsa has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Menzek
Department of EADM, Faculty of Health Sciences, Ardahan University, 75002 Ardahan, Turkiye; Department of Chemistry, Faculty of Science, Atatürk University, 25240 Erzurum, Turkiye
1 shared publication - Ali Ganji
Department of Immunology, School of Medicine, Arak university of Medical Sciences, Arak, Iran
1 shared publication - Azizeh Shadidizaji
Atatürk University
1 shared publication - Bahram Mohammadi
Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
1 shared publication - Dilanur Ateş
Atatürk University
1 shared publication - Farhad Jadidi-Niaragh
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication
Latest Publications
- Open Access
- 3 May 2024
- Published by Ataturk Universitesi in Recent Trends in Pharmacology
- Vol. 2 (1) , 27-35
In Silico Elucidation of the Binding Mechanisms and Molecular Dynamics of Oroxylin A -2,3-Dioxygenase Interaction: An Insight into Therapeutic Potentiation of Quercetin’s Cardioprotection.
Elucidating the intricate interplay between enzymes and natural compounds is essential for designing therapeutic strategies. This study employs advanced computational techniques to explore the binding mechanisms between quercetin 2,3-dioxygenase (QDO) and oroxylin A, revealing specific interaction patterns and key residues crucial to the formation of the QDO-oroxylin A complex. Molecular docking simulations revealed a favorable binding affinity (docking score: -5.6 kcal/mol) between Oroxylin A and the active site cavity of QDO, which was supported by Oroxylin A's specific orientation (Pose 3). Despite an observed RMSD value of 2.776 indicating a moderate deviation between the docked pose and the reference structure, the formation of two hydrogen bonds with GLN 93 chain D underscores specific molecular interactions driving the binding process. This hydrogen bond formation suggested the presence of a stable and specific binding mode between Oroxylin A and QDO, likely influencing the functional dynamics of the enzyme, necessitating further refinement and validation of the docking model. The ensuing deliberation on the implications of Oroxylin A include its potential as a modulator of QDO activity, emphasizing the importance of molecular-level insights in comprehending enzyme-compound interactions. Oroxylin A, a quercetin 2,3-dioxygenase inhibitor, was used in combination with other agents to prolong the biological impacts of quercetin, thereby amplifying its antioxidant and anti-inflammatory effects. This strategic approach exhibits promise in augmenting cardioprotective benefits, immune system support, and protection against diverse pathological conditions. Subsequent considerations of dosage, bioavailability, and healthcare professional consultation are imperative for judicious supplementation, particularly in individuals with prevailing health conditions or medications. This ongoing in silico study is dedicated to revealing the potential synergistic interactions of Oroxylin A, potentiating the long-term effects of quercetin and advancing our understanding of these intricacies.
- 3 May 2024
- Published by Ataturk Universitesi in Recent Trends in Pharmacology
- Vol. 2 (1) , 27-35
Open AccessIn Silico Elucidation of the Binding Mechanisms and Molecular Dynamics of Oroxylin A -2,3-Dioxygenase Interaction: An Insight into Therapeutic Potentiation of Quercetin’s Cardioprotection.
Elucidating the intricate interplay between enzymes and natural compounds is essential for designing therapeutic strategies. This study employs advanced computational techniques to explore the binding mechanisms between quercetin 2,3-dioxygenase (QDO) and oroxylin A, revealing specific interaction patterns and key residues crucial to the formation of the QDO-oroxylin A complex. Molecular docking simulations revealed a favorable binding affinity (docking score: -5.6 kcal/mol) between Oroxylin A and the active site cavity of QDO, which was supported by Oroxylin A's specific orientation (Pose 3). Despite an observed RMSD value of 2.776 indicating a moderate deviation between the docked pose and the reference structure, the formation of two hydrogen bonds with GLN 93 chain D underscores specific molecular interactions driving the binding process. This hydrogen bond formation suggested the presence of a stable and specific binding mode between Oroxylin A and QDO, likely influencing the functional dynamics of the enzyme, necessitating further refinement and validation of the docking model. The ensuing deliberation on the implications of Oroxylin A include its potential as a modulator of QDO activity, emphasizing the importance of molecular-level insights in comprehending enzyme-compound interactions. Oroxylin A, a quercetin 2,3-dioxygenase inhibitor, was used in combination with other agents to prolong the biological impacts of quercetin, thereby amplifying its antioxidant and anti-inflammatory effects. This strategic approach exhibits promise in augmenting cardioprotective benefits, immune system support, and protection against diverse pathological conditions. Subsequent considerations of dosage, bioavailability, and healthcare professional consultation are imperative for judicious supplementation, particularly in individuals with prevailing health conditions or medications. This ongoing in silico study is dedicated to revealing the potential synergistic interactions of Oroxylin A, potentiating the long-term effects of quercetin and advancing our understanding of these intricacies.
- Open Access
- 2 July 2021
- Published by Maad Rayan Publishing Company in Journal of Herbmed Pharmacology
- Vol. 10 (3) , 344-350
Chemical composition and cytotoxic activity of the essential oil from the aerial parts ofDorema aucheri
Introduction: Herbal products are beneficial compounds with many applications in human life. In this study the chemical composition and cytotoxic activity of the essential oil of the aerial parts of Dorema aucheri were assessed. Methods: The essential oil was extracted by hydrodistillation after drying the aerial parts of D. aucheri, collected from the mountains around Yasuj city in the South-West of Iran. The oil composition was determined by GC/MS. To evaluate in vitro cytotoxic activity, the apoptotic effects of the essential oil were investigated against SW48 and SW1116 colorectal cancer cell lines by (3-[4, 5-dimethylthiazol-2-yl]-2, 5 diphenyl tetrazolium) bromide (MTT) assay and flow cytometry. Results: The essential oil yield was obtained 0.02% (W/W). Twenty-five compounds were identified in the oil, and the main constituents were caryophyllene (E) (31.29%), Phytol (14.92%), gurjunene (β-) (9.84%), 3,7,11,15-tetramethyl-2-hexadecen-1-ol (8.7%), and n-hexadecanoic acid (8.09%). The MTT assay showed that the IC50 values of the essential oil for SW48 and SW1116 cell lines were 1.4 and 1.2 mg/mL, respectively. The results of flow cytometry showed that the essential oil significantly increased the apoptosis in SW48 cell line compared with the vincristine (P < 0.05). It also increased the apoptosis in SW1116 cells compared with the vincristine, but this difference is not significant. Conclusion: The essential oil of D. aucheri consisted of high amounts of caryophyllene and showed significant cytotoxic effects against SW48 and SW1116 cancerous cell lines.
- 2 July 2021
- Published by Maad Rayan Publishing Company in Journal of Herbmed Pharmacology
- Vol. 10 (3) , 344-350
Open AccessChemical composition and cytotoxic activity of the essential oil from the aerial parts ofDorema aucheri
Introduction: Herbal products are beneficial compounds with many applications in human life. In this study the chemical composition and cytotoxic activity of the essential oil of the aerial parts of Dorema aucheri were assessed. Methods: The essential oil was extracted by hydrodistillation after drying the aerial parts of D. aucheri, collected from the mountains around Yasuj city in the South-West of Iran. The oil composition was determined by GC/MS. To evaluate in vitro cytotoxic activity, the apoptotic effects of the essential oil were investigated against SW48 and SW1116 colorectal cancer cell lines by (3-[4, 5-dimethylthiazol-2-yl]-2, 5 diphenyl tetrazolium) bromide (MTT) assay and flow cytometry. Results: The essential oil yield was obtained 0.02% (W/W). Twenty-five compounds were identified in the oil, and the main constituents were caryophyllene (E) (31.29%), Phytol (14.92%), gurjunene (β-) (9.84%), 3,7,11,15-tetramethyl-2-hexadecen-1-ol (8.7%), and n-hexadecanoic acid (8.09%). The MTT assay showed that the IC50 values of the essential oil for SW48 and SW1116 cell lines were 1.4 and 1.2 mg/mL, respectively. The results of flow cytometry showed that the essential oil significantly increased the apoptosis in SW48 cell line compared with the vincristine (P < 0.05). It also increased the apoptosis in SW1116 cells compared with the vincristine, but this difference is not significant. Conclusion: The essential oil of D. aucheri consisted of high amounts of caryophyllene and showed significant cytotoxic effects against SW48 and SW1116 cancerous cell lines.